This $166,059 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund research at Carnegie Mellon University to study the prevalence, developmental trajectories, and risk/protective factors associated with solitary alcohol use among young adults in the United States. The research aims to: 1) Estimate the prevalence of solitary alcohol use among 18-30 year olds over time, 2) Model developmental patterns of...
This $302,024 Project Grant was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the federal Alcohol Research Programs (CFDA 93.273) on September 14, 2023. The grant supports a research project by the Research Foundation of the City University of New York (RFCUNY) to assess the impacts of increased alcohol home delivery during the COVID-19 pandemic. The project aims to: 1) document compliance with age verification policies during alcohol home deliveries, 2)...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), under its Alcohol Research Programs (CFDA 93.273), awarded a $640,010 Project Grant to Vanderbilt University to conduct a 5-year study on the perceived norms around alcohol use and HIV/STI prevention among adolescents and young adults in rural Uganda. The study aims to: 1) use qualitative methods to explore perceived norms around alcohol, HIV/STI transmission risk, and HIV/STI prevention; 2) estimate the causal effects of...
This three-year, $855,106 project grant from the National Institute on Alcohol Abuse and Alcoholism will fund research at the Reed Institute examining the impact of gender identification and group dynamics on alcohol-related decision making among emerging adults ages 18 to 25. The grant aims to recruit 260 participants identifying as cisgender or gender diverse to participate in automated simulations and interviews exploring how social contexts like group size and gender composition influence...
This Project Grant award for $516,146, awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), aims to examine the use of transdermal alcohol concentration (TAC) biosensors to better understand alcohol-induced blackouts (AIBs) and their relationship to other harmful consequences among young adults. The research, being conducted by the University of Oklahoma Health Sciences Center and Penn State, has two primary objectives: 1)...
This federal Project Grant award, funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), provides $150,497 to the Ann & Robert H. Lurie Children's Hospital of Chicago to adapt and implement the Screening, Brief Intervention, and Referral to Treatment (SBIRT) approach for adolescents with chronic medical conditions (A-CMC) who are hospitalized in pediatric inpatient units. The key objectives of this 5-year project are to: 1)...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $481,428 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the Moses-Weitzman Health System, Inc. on September 20, 2024. The project, titled "Translating Research into Practice on Alcohol and Polysubstance Use Disorders by Educating the Interprofessional Primary Care Team," aims to improve the capacity of primary care providers in federally qualified health centers and other safety net settings to...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, aims to study the effects of cannabis use on treatment outcomes for adolescents with alcohol use disorder (AUD) and co-occurring psychiatric disorders (CODs) in community-based treatment settings. The $197,262 award will leverage mixed methods, including qualitative interviews, an ecological momentary assessment pilot, and...
This federal Project Grant award of $710,992, provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), supports a longitudinal study to understand the trajectory, mechanisms, and impacts of changes in emotion processing deficits during early alcohol use disorder (AUD) recovery. The University of Florida, the primary awardee, will recruit recently abstinent individuals in residential AUD treatment and a matched community control...
This Project Grant award of $1,227,554.00 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund a prospective examination of transdermal alcohol concentration (TAC) features as predictors of alcohol-related consequences and alcohol use disorders (AUDs) among 500 young adults. The research aims to: 1) examine TAC features as predictors of alcohol-related consequences, relative to ecological momentary assessment (EMA)...
UNDERSTANDING HOW ALCOHOL USE AFFECTS ADOLESCENT COVID-19 ACQUISITION AND DISEASE COURSE OVERTIME - ONE IN SIX 14-17 YEAR-OLDS (16.3%) HAVE TESTED POSITIVE FOR COVID-19. UNDERSTANDING THE FACTORS THAT CONFER INCREASED RISK IS IMPERATIVE GIVEN ADOLESCENTS' VULNERABLE DEVELOPMENTAL STAGE. ONE PARTICULARLY SALIENT RISK FACTOR MAY BE ALCOHOL USE, BOTH BECAUSE INTENSE ALCOHOL USE NEGATIVELY IMPACTS IMMUNE SYSTEM FUNCTIONING AND SLEEP PATTERNS, AND ALSO BECAUSE CONSUMING ALCOHOL WITH OTHERS COULD LEAD TO LOWERED INHIBITIONS THAT RESULT IN REDUCED SOCIAL DISTANCING. COVID-19 ALSO MAY BE IMPACTING THE WAY IN WHICH ADOLESCENTS CONSUME ALCOHOL, POTENTIALLY WITH LIFE-LONG CONSEQUENCES. UNDERSTANDING HOW PANDEMIC EXPERIENCES HAVE AFFECTED THE FREQUENCY AND INTENSITY OF ALCOHOL USE IS NECESSARY FOR ENSURING SUFFICIENT TREATMENT SUPPORTS FOR YOUTH. IT ALSO IS CRUCIAL TO KNOW HOW ALCOHOL MAY AFFECT THE COVID-19 DISEASE COURSE, INCLUDING THE SEVERITY AND LONG-TERM IMPACT ON SOMATIC AND MENTAL HEALTH. THE PANDEMIC ALSO HAS REIFIED LONG-STANDING HEALTH INEQUITIES. INDEED, DATA OVERWHELMING SUGGEST THAT BLACK/AFRICAN AMERICAN AND HISPANIC PEOPLE ARE SIGNIFICANTLY MORE LIKELY TO ACQUIRE COVID-19, AND TO HAVE A WORSE DISEASE COURSE. THE SAME IS TRUE FOR PEOPLE WHO IDENTIFY AS A SEXUAL AND GENDER MINORITY (SGM). BEFORE THE PANDEMIC, HIGH SCHOOL-AGED SGM YOUTH REPORTED HIGHER RATES OF ALCOHOL USE THAN NON-SGM YOUTH, WHEREAS RATES WERE SIMILAR FOR HISPANIC AND WHITE YOUTH AND SIGNIFICANTLY LOWER FOR BLACK/AFRICAN AMERICAN YOUTH. ENSURING THAT WE UNDERSTAND HOW PANDEMIC EXPERIENCES AND ALCOHOL TOGETHER MAY BE CONFERRING RISK SIMILARLY AND DIFFERENTLY FOR THESE MINORITY ADOLESCENT POPULATIONS IS FUNDAMENTAL TO ADDRESSING DISPARITIES. IN RESPONSE TO RFA-AA-21-002, WE PROPOSE TO RECRUIT AND SURVEY 2,500 14-18 YEAR-OLDS, 500 OF WHOM WILL HAVE TESTED POSITIVE FOR COVID-19 IN THE PAST 3 MONTHS AND 2,000 OF WHOM WILL HAVE NEVER TESTED POSITIVE FOR COVID-19. USING PROCEDURES SUCCESSFULLY IMPLEMENTED BY THE RESEARCH TEAM PREVIOUSLY, ADOLESCENTS WILL BE RECRUITED ON SOCIAL MEDIA AND SURVEYED ONLINE. THIS WILL AFFORD A NATIONAL SCOPE WHILE EMPOWERING YOUTH TO ENGAGE IN THIS SENSITIVE SURVEY TOPIC WHERE AND WHEN IT IS SAFE FOR THEM. YOUTH WHO HAVE TESTED POSITIVE FOR COVID-19 AT BASELINE WILL BE ASKED TO RETROSPECTIVELY REPORT THEIR DISEASE SEVERITY, PROGRESSION, AND OUTCOMES, AS WELL AS THEIR CURRENT COVID-19-RELATED SYMPTOMS. BOTH YOUTH WHO HAVE BEEN POSITIVE AND THOSE WHO ARE NEGATIVE FOR COVID-19 WILL PROVIDE INFORMATION ABOUT THEIR PAST AND CURRENT ALCOHOL USE, AS WELL AS PAST AND CURRENT COVID-PROTECTIVE AND -RISK BEHAVIORS. ALL YOUTH THEN WILL BE PROSPECTIVELY FOLLOWED FOR 24 MONTHS. THEY WILL COMPLETE COMPREHENSIVE ONLINE SURVEYS AT 6-, 12-, 18- AND 24-MONTHS, AND BRIEF, MONTHLY SURVEYS THAT QUERY THE KEY EXPOSURES AND OUTCOMES IN THE IN-BETWEEN MONTHS. OUR MAIN EXPOSURES WILL BE 1) ALCOHOL USE IN THE PAST 30 DAYS, 2) BINGE DRINKING IN THE PAST 30 DAYS, AND 3) ALCOHOL USE DISORDER. OUR MAIN OUTCOME MEASURES WILL BE: 1) COVID-19 ACQUISITION; 2) THE EXTENT OF AND 3) LENGTH TO WHICH SYMPTOMS ARE EXPERIENCED. FINDINGS WILL HAVE BOTH SHORT- AND LONG-TERM IMPACT ON THE PUBLIC HEALTH RESPONSE TO THIS AND FUTURE PANDEMICS.